The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy
Recent antidepressant exposure may reduce the treatment efficacy of MDMA.
Psychotherapy - Page 2
The Problem and Paradox of Bad Trips, Part 2
Transforming a bad trip often means giving it a place and purpose in one’s larger life story.
The Problem and Paradox of Bad Trips – Part 1
Bad trips look much different in psychedelic therapy than in uncontrolled settings.
Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits?
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
Equity and Accessibility of MDMA-Assisted Therapy
Psychedelic medicine continues to move forward, but minority communities are being left behind.
The Top 10 Psychedelic Research Papers of 2020
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration
Harnessing the theoretical and technical synergy between Acceptance and Commitment Therapy (ACT) and Psychedelic Assisted Psychotherapy (PcbAP)
ACT and PcbAP for Depression – A Natural Synergy Part 1: The Theoretical Intersection
Harnessing the theoretical and technical synergy between Acceptance & Commitment Therapy (ACT) and Psilocybin-Assisted Psychotherapy (PcbAP)
Psychedelic-Assisted Therapy in the Post-Pandemic Era
In the wake of Covid-19, psychedelic-assisted therapy is gaining attention.